The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.14096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Yan Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Innovation and Attracting Talents "111" base, Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bio…. Hauptthemen laut MEDLINE: NF-kappa B, Chondrocytes, Osteoarthritis, Knee, Macrophages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation and Attracting Talents Program for College and University.
Abstract (Originalsprache)
Chronic inflammation significantly contributes to the progression of osteoarthritis (OA), and an anti‐inflammatory small molecule derived from medicinal herbs could be a potential drug candidate for OA. Herein, we investigated the function and mechanism of Evodiamine (EAE), the active ingredient from Evodia rutaecarpa , in chondrocytes and macrophages in vitro and in vivo. The cytotoxicity of EAE was determined using an MTT assay. And the anti‐inflammatory and anti‐extracellular matrix (ECM) degradation effects of EAE were investigated using qRT‐PCR, western blot (WB), immunofluorescence (IF). Inductively Coupled Plasma Atomic Emission Spectrometry (ICP‐AES), Fluo‐4 AM, IF and AutoDock were used to elucidate the molecular mechanisms and signalling pathways of the reducing‐inflammatory properties of EAE on chondrocytes in vitro. Moreover, the effect of EAE on macrophage polarization was detected by IF and flow cytometry (FC). Ultimately, we explored the in vivo therapeutic efficacy of EAE in an anterior cruciate ligament transection (ACLT)‐induced OA model. The finding demonstrated that EAE blocked the phosphorylation of IKBα and Ca 2+ influx, thereby curbing inflammation and ECM degradation. Additionally, EAE can prevent the polarization towards the M1 phenotype. Thus, our findings suggest that EAE has great potential as a therapeutic drug for the treatment of OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Innovation and Attracting Talents "111" base, Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
- College of Biology and Environmental Sciences, Jishou University, Jishou, China.
ORCID-Profile: Li Yang
Förderung
- National Natural Science Foundation of China
- Innovation and Attracting Talents Program for College and University
Zitieren
APA
Gao, Y., Wang, S., Gao, Y., & Yang, L. (2024). The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14096
Vancouver
Gao Y, Wang S, Gao Y, Yang L. The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14096
BibTeX
@article{Gao2024,
author = {Gao, Yan and Wang, Sixiang and Gao, Yuehong and Yang, Li},
title = {The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.14096}
}
EUVIMED